Literature DB >> 17845885

Staphylococcus hominis native mitral valve bacterial endocarditis (SBE) in a patient with hypertrophic obstructive cardiomyopathy.

Burke A Cunha1, Michael D Esrick, Melissa Larusso.   

Abstract

There are several species of coagulase-negative Staphylococci (CoNS) that are part of the normal skin flora and are relatively noninvasive/low virulence organisms. CoNS are important pathogens in patients with prosthetic devices and are the most common pathogen associated with prosthetic valve endocarditis. CoNS native valve infective endocarditis (IE) is rare. Patients with hypertrophic obstructive cardiomyopathy and an outflow pressure gradient greater than 30 mm Hg are predisposed to IE. There has been only one reported case of non-mitral valve IE due to CoNS in a patient with hypertrophic obstructive cardiomyopathy. To the best of our knowledge, we report the first case of Staphylococcal hominis mitral valve endocarditis in a patient with hypertrophic obstructive cardiomyopathy.

Entities:  

Mesh:

Year:  2007        PMID: 17845885     DOI: 10.1016/j.hrtlng.2006.11.002

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  7 in total

Review 1.  Coagulase-negative staphylococci.

Authors:  Karsten Becker; Christine Heilmann; Georg Peters
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Percutaneous Removal of a Cardiac Mass in a Patient with Infective Endocarditis: A Case Report.

Authors:  Nii Koney; Chelsea Benmessaoud; Kalonji Y Cole; Yonca Bulut; Eric H Yang; John M Moriarty
Journal:  J Pediatr Intensive Care       Date:  2018-10-24

3.  Comparison of the etiological relevance of Staphylococcus haemolyticus and Staphylococcus hominis.

Authors:  Hagen Frickmann; Andreas Hahn; Romy Skusa; Nils Mund; Vivian Viehweger; Thomas Köller; Kerstin Köller; Norbert Georg Schwarz; Karsten Becker; Philipp Warnke; Andreas Podbielski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-19       Impact factor: 3.267

4.  Draft Genome Sequence of Staphylococcus hominis BHG17 Isolated from Wild Bar-Headed Goose (Anser indicus) Feces.

Authors:  Wen Wang; Si-Si Zheng; Kirill Sharshov; Hao Sun; Xian-Qiang Wu; Fang Yang; Xue-Lian Wang; Lai-Xing Li
Journal:  Genome Announc       Date:  2017-02-02

5.  Multilocus sequence typing and further genetic characterization of the enigmatic pathogen, Staphylococcus hominis.

Authors:  Liangfen Zhang; Jonathan C Thomas; Maria Miragaia; Ons Bouchami; Fernando Chaves; Pedro A d'Azevedo; David M Aanensen; Herminia de Lencastre; Barry M Gray; D Ashley Robinson
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

6.  Microbiological and molecular characterization of Staphylococcus hominis isolates from blood.

Authors:  Soraya Mendoza-Olazarán; Rayo Morfin-Otero; Eduardo Rodríguez-Noriega; Jorge Llaca-Díaz; Samantha Flores-Treviño; Gloria Ma González-González; Licet Villarreal-Treviño; Elvira Garza-González
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

7.  Antibiotic Susceptibility of Biofilm Cells and Molecular Characterisation of Staphylococcus hominis Isolates from Blood.

Authors:  Soraya Mendoza-Olazarán; Rayo Morfín-Otero; Licet Villarreal-Treviño; Eduardo Rodríguez-Noriega; Jorge Llaca-Díaz; Adrián Camacho-Ortiz; Gloria M González; Néstor Casillas-Vega; Elvira Garza-González
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.